HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay.

AbstractBACKGROUND:
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is an increasingly recognized form of spastic ataxia worldwide, but early diagnosis remains a challenge.
METHODS:
We reviewed the initial presentation (n = 40) and early clinical evolution (n = 50) of a large ARSACS cohort that was followed at the Saguenay Neuromuscular clinic.
RESULTS:
The average age at presentation was 3.41 ± 1.55 years. Increased deep tendon reflexes were more common than spasticity initially, and the neuropathy only became apparent clinically in the second decade. Despite a homogeneous genetic background, some patients showed no signs of neuropathy or spasticity by the age of 18 years.
CONCLUSIONS:
At presentation, ARSACS lacks certain features that are considered typical in adults after years of evolution. Considering that ARSACS is probably under-diagnosed, it should be included in the differential diagnosis of early onset ataxias with or without pyramidal features and is worthwhile to consider in older patients, even when some features are absent.
AuthorsAntoine Duquette, Bernard Brais, Jean-Pierre Bouchard, Jean Mathieu
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 28 Issue 14 Pg. 2011-4 (Dec 2013) ISSN: 1531-8257 [Electronic] United States
PMID23913799 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 Movement Disorder Society.
Topics
  • Adolescent
  • Disease Progression
  • Female
  • Humans
  • Male
  • Muscle Spasticity (diagnosis, physiopathology)
  • Spinocerebellar Ataxias (congenital, diagnosis, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: